Appendix B: The Guideline Review Panel

Appendix B: The Guideline Review Panel

The Guideline Review Panel is an independent panel that oversees the development of the guideline and takes responsibility for monitoring adherence to NICE guideline development processes. In particular, the panel ensures that stakeholder comments have been adequately considered and responded to. The panel includes members from the following perspectives: primary care, secondary care, lay, public health and industry.

Robert Walker (Chair)
General Practitioner

Robin Beal
Secondary care member

Ailsa Donnelly
Lay member

John Harley
Clinical Governance and Prescribing Lead, North Tees PCT

Mark Hill
Head of Medical Affairs, Novartis Pharmaceuticals UK

  • National Institute for Health and Care Excellence (NICE)